ROIVANT SCIENCES LTD
ROIV
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Roivant Sciences Ltd. is a biopharmaceutical company whose business model is built on acquiring and developing drug candidates, which inherently requires animal testing for preclinical safety and efficacy studies as part of the regulatory approval process. The company's pipeline and development strategy are dependent on this standard industry practice.
While specific details of its internal animal testing protocols are not publicly documented in the provided sources, the company's SEC filings acknowledge that clinical trials may fail to demonstrate evidence of safety and efficacy for its product candidates. This development process universally involves animal experimentation. The company's controlling ownership stake in its subsidiary, Immunovant, further extends this model across its network of "Vant" companies.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.